Live from the NIH registry
Studies recruiting near Baltimore right now
Top 25 of 1,648 recruiting studies, sorted by proximity — each links to its official registry page
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
John's Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Sidney Kimmel Comprehensive Cancer Center (SKCCC) at Johns Hopkins — Baltimore, Maryland (1.0 mi)
· Sponsor: Relay Therapeutics, Inc.
Escitalopram and Language Intervention for Subacute Aphasia
Aphasia, Stroke
Phase 2
Interventional 88 participants sought
Johns Hopkins School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
The Retina Care Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Genentech, Inc.
Cabotegravir-Hormone PK/PD Interactions for HIV Prevention
HIV, Prophylaxis
Phase 1
Interventional 32 participants sought
Johns Hopkins School of Medicine, Drug Development Unit — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Amyotrophic Lateral Sclerosis
Phase 3
Interventional 495 participants sought
Johns Hopkins Medicine Brain Science Institute — Baltimore, Maryland (1.0 mi)
· Sponsor: AB Science
Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
Human Papilloma Virus, Anal Dysplasia
Phase 2
Interventional 120 participants sought
RIIS Clinic at Baltimore Safe Haven — Baltimore, Maryland (1.0 mi)
· Sponsor: University of Maryland, Baltimore
Semaglutide Therapy for Alcohol Reduction (STAR)
Addiction, Alcohol Use Disorder
Phase 2
Interventional 80 participants sought
National Institute on Drug Abuse — Baltimore, Maryland (1.0 mi)
· Sponsor: National Institute on Drug Abuse (NIDA)
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 260 participants sought
Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Bristol-Myers Squibb
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
Adult Congenital Heart Disease, Congenital Heart Disease
N/A
Observational 400 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Leiden University Medical Center
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
Renal Cell Carcinoma
Phase 3
Interventional 904 participants sought
Greater Baltimore Medical Center ( Site 0145) — Baltimore, Maryland (1.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study to Examine the Effect of Silicone Mouth Tape on Snoring and Mild Sleep Apnea.
Mild Obstructive Sleep Apnea, Snoring
Phase 2
Interventional 100 participants sought
Johns Hopkins Bayview Medical Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
University of Maryland — Baltimore, Maryland (1.0 mi)
· Sponsor: Cook Research Incorporated
Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Phase 1
Interventional 50 participants sought
Tania Jain, MD — Baltimore, Maryland (1.0 mi)
· Sponsor: Catherine Bollard
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
Systemic Lupus Erythematosus
Phase 3
Interventional 550 participants sought
University Of Maryland — Baltimore, Maryland (1.0 mi)
· Sponsor: Novartis Pharmaceuticals
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
Tibial Fractures, Pain
Phase 3
Interventional 1,000 participants sought
University of Maryland R Adams Cowley Shock Trauma Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Major Extremity Trauma Research Consortium
Transcutaneous Spinal Cord Stimulation in Children With Incomplete Spinal Cord Injury
Spinal Cord Injuries
N/A
Interventional 20 participants sought
Kennedy Krieger Institute — Baltimore, Maryland (1.0 mi)
· Sponsor: Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Geographic Atrophy, Macular Degeneration
N/A
Observational 500 participants sought
Retina Specialists — Towson, Maryland (6.7 mi)
· Sponsor: Astellas Pharma Global Development, Inc.
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
Ulcerative Colitis, Crohn's Disease
Phase 3
Interventional 240 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Takeda
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
Atherosclerotic Cardiovascular Disease (ASCVD)
Phase 3
Interventional 340 participants sought
Flourish Research Bowie — Bowie, Maryland (25.8 mi)
· Sponsor: Novartis Pharmaceuticals
Optimizing Reperfusion to Improve Outcomes and Neurologic Function
Acute Ischemic Stroke
Phase 2, Phase 3
Interventional 740 participants sought
Corxel Investigational Site — Baltimore, Maryland (1.0 mi)
· Sponsor: Corxel Pharmaceuticals
A Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
Narcolepsy
Phase 2
Interventional 64 participants sought
Wu Lab at Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Eisai Inc.
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
The Johns Hopkins Hospital, The Sidney Kimmel Cancer Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Steba Biotech S.A.
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
Maryland Proton Treatment Center — Baltimore, Maryland (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)
Endometriosis
N/A
Observational 1,200 participants sought
Johns Hopkins School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Aspira Women's Health